- Home
- GENK vs NXPL Comparison
GENK vs NXPL Comparison
Compare GENK & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- NXPL
- Stock Information
- Founded
- GENK 2011
- NXPL 1997
- Country
- GENK United States
- NXPL United States
- Employees
- GENK N/A
- NXPL N/A
- Industry
- GENK Restaurants
- NXPL Telecommunications Equipment
- Sector
- GENK Consumer Discretionary
- NXPL Telecommunications
- Exchange
- GENK Nasdaq
- NXPL Nasdaq
- Market Cap
- GENK 20.4M
- NXPL 17.9M
- IPO Year
- GENK 2023
- NXPL N/A
- Fundamental
- Price
- GENK $4.03
- NXPL $0.76
- Analyst Decision
- GENK Strong Buy
- NXPL
- Analyst Count
- GENK 2
- NXPL 0
- Target Price
- GENK $10.00
- NXPL N/A
- AVG Volume (30 Days)
- GENK 59.5K
- NXPL 32.4K
- Earning Date
- GENK 07-30-2025
- NXPL 08-13-2025
- Dividend Yield
- GENK 0.78%
- NXPL N/A
- EPS Growth
- GENK N/A
- NXPL N/A
- EPS
- GENK N/A
- NXPL N/A
- Revenue
- GENK $214,957,000.00
- NXPL $62,515,000.00
- Revenue This Year
- GENK $16.62
- NXPL N/A
- Revenue Next Year
- GENK $20.40
- NXPL N/A
- P/E Ratio
- GENK N/A
- NXPL N/A
- Revenue Growth
- GENK 14.40
- NXPL 19.36
- 52 Week Low
- GENK $3.16
- NXPL $0.43
- 52 Week High
- GENK $10.33
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- GENK 49.22
- NXPL 62.83
- Support Level
- GENK $3.80
- NXPL $0.68
- Resistance Level
- GENK $4.07
- NXPL $0.85
- Average True Range (ATR)
- GENK 0.23
- NXPL 0.07
- MACD
- GENK 0.02
- NXPL 0.00
- Stochastic Oscillator
- GENK 58.09
- NXPL 61.74
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.